Tarapeutics Science Inc.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

1. Trial

   NA registered

   May 25, 2026

   Autism Spectrum Disorder · RECRUITING · sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Transcranial Temporal Interference Stimulation for Children With Autism Spectrum Disorders

   ClinicalTrials.gov · NCT07625748 (opens the source filing in a new tab)

2. Trial

   NA registered

   May 1, 2026

   Cardiac Surgery, Hypertension, Pulmonary · SUSPENDED · sponsor: Qianfoshan Hospital · The Effect of Pituitrin on the Patients With Pulmonary Hypertension Undergoing Cardiac Surgery

   ClinicalTrials.gov · NCT05727618 (opens the source filing in a new tab)

3. Trial

   Study registered

   Mar 20, 2026

   Acute Myeloid Leukemia (AML) · RECRUITING · sponsor: Peking University People's Hospital · Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML

   ClinicalTrials.gov · NCT07500441 (opens the source filing in a new tab)

4. Trial

   EARLY_PHASE1 registered

   Feb 28, 2026

   B-Cell Acute Lymphoblastic Leukemia · RECRUITING · sponsor: Zhejiang University · Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia

   ClinicalTrials.gov · NCT07429461 (opens the source filing in a new tab)

5. Trial

   PHASE2 registered

   Feb 15, 2026

   Oral Mucositis, Stomatitis, Gastrointestinal Mucositis, Hematopoietic Stem Cell Transplantation · RECRUITING · sponsor: The First Affiliated Hospital of Soochow University · Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients

   ClinicalTrials.gov · NCT07400328 (opens the source filing in a new tab)

6. Trial

   PHASE1 registered

   Jan 2, 2026

   B-ALL · RECRUITING · sponsor: Zhejiang University · KSV01 Injection as the Therapy for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

   ClinicalTrials.gov · NCT07246707 (opens the source filing in a new tab)

7. Trial

   PHASE2 registered

   Nov 30, 2025

   ALL · RECRUITING · sponsor: Zhejiang University · A Multicenter Study of CAR-T Cells in Primary Ph+All

   ClinicalTrials.gov · NCT07252336 (opens the source filing in a new tab)

8. Trial

   PHASE3 registered

   Nov 20, 2025

   Resistant Hypertension · NOT_YET_RECRUITING · sponsor: Yan Li · Perirenal Adipose Tissue Modification Therapy for Resistant Hypertension

   ClinicalTrials.gov · NCT07232966 (opens the source filing in a new tab)

9. Trial

   NA registered

   Oct 1, 2025

   Aplastic Anaemia · RECRUITING · sponsor: The First Affiliated Hospital of Soochow University · A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic Anemia

   ClinicalTrials.gov · NCT07499284 (opens the source filing in a new tab)

10. Trial

    EARLY_PHASE1 registered

    Sep 5, 2025

    Acute Myeloid Leukemia · RECRUITING · sponsor: Zhejiang University · Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia

    ClinicalTrials.gov · NCT07144020 (opens the source filing in a new tab)

11. Trial

    PHASE1 registered

    Aug 15, 2025

    MDS, AML · NOT_YET_RECRUITING · sponsor: Anhui Provincial Hospital · QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS)

    ClinicalTrials.gov · NCT07131085 (opens the source filing in a new tab)

12. Trial

    NA registered

    Jul 15, 2025

    Spinal Cord Injury, Mental Health, Feasibility Studies, Acceptability Study, Spinal Cord Injuries (SCI), Spinal Cord Injuries, Coping · COMPLETED · sponsor: The Hong Kong Polytechnic University · A Feasibility Trial of an Enhanced Coping-oriented Supportive Programme for Community-dwelling People With Spinal Cord Injury

    ClinicalTrials.gov · NCT07170969 (opens the source filing in a new tab)

13. Trial

    PHASE2 registered

    Jul 14, 2025

    Cancer Treatment-induced Thrombocytopenia (CTIT) · RECRUITING · sponsor: Anhui Provincial Hospital · Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced Thrombocytopenia (CTIT) in the Treatment of Leukemia

    ClinicalTrials.gov · NCT06898983 (opens the source filing in a new tab)

14. Trial

    PHASE3 registered

    Jul 11, 2025

    Acute Graft Versus Host Disease · RECRUITING · sponsor: Anhui Provincial Hospital · Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies Post UCBT

    ClinicalTrials.gov · NCT07047456 (opens the source filing in a new tab)

15. Trial

    NA registered

    Jul 1, 2025

    Autism Spectrum Disorder · COMPLETED · sponsor: Fei Li · Temporal Pole Transcranial Alternating Current Stimulation for Children With Autism Spectrum Disorder

    ClinicalTrials.gov · NCT07045584 (opens the source filing in a new tab)

16. Trial

    NA registered

    May 16, 2025

    Intratracheal Intubation, Patient Positioning · COMPLETED · sponsor: Shandong Provincial Hospital · Effectiveness of Detachment of the Breathing Circuit on the Rate of DLT Malposition After Postural Change

    ClinicalTrials.gov · NCT06182371 (opens the source filing in a new tab)

17. Trial

    EARLY_PHASE1 registered

    Apr 3, 2025

    Relapsed / Refractory Autoimmune Hemolytic Anemia · NOT_YET_RECRUITING · sponsor: Zhejiang University · UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Autoimmune Hemolytic Anemia

    ClinicalTrials.gov · NCT06920446 (opens the source filing in a new tab)

18. Trial

    EARLY_PHASE1 registered

    Apr 1, 2025

    Myasthenia Gravis · NOT_YET_RECRUITING · sponsor: Zhejiang University · UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Myasthenia Gravis

    ClinicalTrials.gov · NCT06933563 (opens the source filing in a new tab)

19. Trial

    PHASE2 registered

    Apr 1, 2025

    Autism Spectrum Disorder · COMPLETED · sponsor: Fei Li · Efficacy of Nutritional Supplements on Children With Autism Spectrum Disorder

    ClinicalTrials.gov · NCT06911905 (opens the source filing in a new tab)

20. Trial

    NA registered

    Feb 15, 2025

    Acute Pain · RECRUITING · sponsor: The Second Affiliated Hospital of Chongqing Medical University · Effect of Remote Local Peripheral Nerve Cooling on Pain of Arterial Puncture

    ClinicalTrials.gov · NCT06838572 (opens the source filing in a new tab)

21. Trial

    EARLY_PHASE1 registered

    Jan 31, 2025

    Lupus Nephritis · RECRUITING · sponsor: He Huang · CD19/BCMA CAR-T Cell Therapy for Refractory/Relapsed Lupus Nephritis

    ClinicalTrials.gov · NCT06785519 (opens the source filing in a new tab)

22. Trial

    NA registered

    Jan 30, 2025

    Chronic Kidney Disease(CKD), Nocturnal Hypertension · NOT_YET_RECRUITING · sponsor: Shanghai Institute of Hypertension · Protecting Renal Function in Chronic Kidney Disease Patients with Isolated Nighttime Hypertension

    ClinicalTrials.gov · NCT06780865 (opens the source filing in a new tab)

23. Trial

    EARLY_PHASE1 registered

    Jan 10, 2025

    Autoimmune Diseases · NOT_YET_RECRUITING · sponsor: Zhejiang University · A Study of CAR-T Cells in Subjects with Autoimmune Diseases

    ClinicalTrials.gov · NCT06762119 (opens the source filing in a new tab)

24. Trial

    PHASE1 registered

    Jan 8, 2025

    Relapsed/Refractory Acute Myeloid Leukemia(AML) · SUSPENDED · sponsor: He Huang · A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/Refractory Acute Myeloid Leukemia

    ClinicalTrials.gov · NCT06709131 (opens the source filing in a new tab)

25. Trial

    EARLY_PHASE1 registered

    Dec 24, 2024

    Systemic Lupus Erythematosus · RECRUITING · sponsor: Zhejiang University · Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Moderate to Severe Active SLE Clinical Research

    ClinicalTrials.gov · NCT06711146 (opens the source filing in a new tab)

26. Trial

    NA registered

    Dec 16, 2024

    Cytomegalovirus Infections, CMV · RECRUITING · sponsor: The First Affiliated Hospital of Soochow University · Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT

    ClinicalTrials.gov · NCT06812598 (opens the source filing in a new tab)

27. Trial

    PHASE1 registered

    Dec 4, 2024

    Refractory Thrombocytopenia · COMPLETED · sponsor: Anhui Provincial Hospital · A Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of MegaLT Injection for Treating Refractory Thrombocytopenia Following Radiotherapy, Chemotherapy, or Transplantation.

    ClinicalTrials.gov · NCT06534255 (opens the source filing in a new tab)

28. Trial

    NA registered

    Nov 24, 2024

    Lung Cancer, Lung Metastases · RECRUITING · sponsor: Oxford University Hospitals NHS Trust · Oxford Pleural Embolisation Trial

    ClinicalTrials.gov · NCT06651658 (opens the source filing in a new tab)

29. Trial

    EARLY_PHASE1 registered

    Sep 5, 2024

    Relapsed/Refractory, Multiple Myeloma · RECRUITING · sponsor: The First Affiliated Hospital of Nanchang University · A Study to Evaluate CG-105-12 in Patients With Relapsed/Refractory Multiple Myeloma

    ClinicalTrials.gov · NCT06999031 (opens the source filing in a new tab)

30. Trial

    PHASE4 registered

    Aug 26, 2024

    Acute Pain, Chronic Pain, Postoperative Pain · RECRUITING · sponsor: The Second Affiliated Hospital of Chongqing Medical University · Efficacy and Safety of Liposomal Bupivacaine Injection for Paravertebral Nerve Block in the Treatment of Acute and Chronic Pain After Thoracoscopic Pneumonectomy: A Multicenter, Randomized, Double-blind, Controlled Clinical Trial

    ClinicalTrials.gov · NCT06569953 (opens the source filing in a new tab)

31. Grant

    R01 · $776k · non-dilutive

    May 1, 2024

    UNIVERSITY OF IOWA · PI MAGNOTTA, VINCENT A · NIA · award ends Jan 31, 2029 · High Resolution MRSI for Alzheimer's Disease and Related Dementias

    NIH RePORTER · NIH RePORTER 11258934 (opens the source filing in a new tab)

32. Grant

    R01 · $582k · non-dilutive

    Mar 1, 2024

    UNIVERSITY OF CHICAGO · PI LI, YAN CHUN · NIDDK · award ends Jan 31, 2028 · Metabolic Regulation of Colonic Senescence and Pathological Implications: Epithelial and Microbial Interactions

    NIH RePORTER · NIH RePORTER 11290312 (opens the source filing in a new tab)

33. Trial

    PHASE3 registered

    Mar 1, 2024

    Acute Graft-versus-host Disease · ACTIVE_NOT_RECRUITING · sponsor: Anhui Provincial Hospital · Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies

    ClinicalTrials.gov · NCT06294678 (opens the source filing in a new tab)

34. Trial

    NA registered

    Feb 10, 2024

    Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD) · RECRUITING · sponsor: Anhui Provincial Hospital · A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD

    ClinicalTrials.gov · NCT06321198 (opens the source filing in a new tab)

35. Trial

    NA registered

    Nov 1, 2023

    Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation · RECRUITING · sponsor: The First Affiliated Hospital of Soochow University · TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT

    ClinicalTrials.gov · NCT06125483 (opens the source filing in a new tab)

36. Trial

    PHASE1/PHASE2 registered

    Oct 19, 2023

    ALL, Adult, AML, Adult, Acute Leukaemia, KMT2A Rearrangement, NPM1 Mutation, NUP98 Gene Rearrangement, Menin Inhibitors · ACTIVE_NOT_RECRUITING · sponsor: Institut de Recherches Internationales Servier (I.R.I.S.) · A Study of BN104 in the Treatment of Acute Leukemia

    ClinicalTrials.gov · NCT06052813 (opens the source filing in a new tab)

37. Trial

    NA registered

    Oct 1, 2023

    Lower Limb Amputation Below Knee (Injury) · RECRUITING · sponsor: North Carolina State University · Restoration of Normative Postural Control

    ClinicalTrials.gov · NCT06452186 (opens the source filing in a new tab)

38. Trial

    PHASE2 registered

    Jul 15, 2023

    T Lymphoblastic Leukemia/Lymphoma · COMPLETED · sponsor: Zhejiang University · Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas

    ClinicalTrials.gov · NCT05991973 (opens the source filing in a new tab)

39. Trial

    PHASE2/PHASE3 registered

    Jul 4, 2023

    Autism Spectrum Disorder · COMPLETED · sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Efficacy and Mechanism of Repetitive Transcranial Magnetic Stimulation in Children With Autism Spectrum Disorders

    ClinicalTrials.gov · NCT05927792 (opens the source filing in a new tab)

40. Trial

    PHASE1 registered

    May 15, 2023

    Neuromyelitis Optica · COMPLETED · sponsor: Zhejiang University · Evaluate the Safety and Efficacy of CAR-T Cells in the Treatment of R/R Neuromyelitis Optica

    ClinicalTrials.gov · NCT05828212 (opens the source filing in a new tab)

41. Trial

    PHASE1/PHASE2 registered

    Apr 30, 2023

    Hematologic Diseases, Neoplasms · RECRUITING · sponsor: Zhejiang University · CD7 CAR-T Bridging to alloHSCT for R/R CD7+Malignant Hematologic Diseases

    ClinicalTrials.gov · NCT05827835 (opens the source filing in a new tab)

42. Trial

    EARLY_PHASE1 registered

    Apr 11, 2023

    Adult Gliomas, Mixed · COMPLETED · sponsor: Robert Bok, MD, PhD · Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma

    ClinicalTrials.gov · NCT05851378 (opens the source filing in a new tab)

43. Trial

    Study registered

    Apr 1, 2023

    CMV Infection, Hematopoietic Stem Cell Transplantation · COMPLETED · sponsor: The First Affiliated Hospital of Soochow University · Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China

    ClinicalTrials.gov · NCT05789615 (opens the source filing in a new tab)

44. Trial

    Study registered

    Mar 1, 2023

    Very Preterm Maturity of Infant, The Risk Factors for Improving the Prognosis of VLBW Infants · COMPLETED · sponsor: Shenzhen Bao'an Maternal and Child Health Hospital · Analyses of Anemia in Very Low Birth Weight (VLBW) Infants.

    ClinicalTrials.gov · NCT05949788 (opens the source filing in a new tab)

45. Grant

    R01 · $653k · non-dilutive

    Feb 21, 2023

    CASE WESTERN RESERVE UNIVERSITY · PI JIN, FULAI · NHGRI · award ends Jan 31, 2027 · Mapping heritable chromatin loop variants with allele-specific Hi-C analysis

    NIH RePORTER · NIH RePORTER 11261234 (opens the source filing in a new tab)

46. Trial

    NA registered

    Oct 1, 2022

    Vaccine Hesitancy, COVID-19 · COMPLETED · sponsor: The Hong Kong Polytechnic University · The Impact of a Web-based Psychoeducation Programme with a Motivational AI Chatbot on Covid-19 Vaccine Hesitancy

    ClinicalTrials.gov · NCT05531058 (opens the source filing in a new tab)

47. Trial

    PHASE1 registered

    Aug 4, 2022

    Hematologic Disease · RECRUITING · sponsor: He Huang · Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation

    ClinicalTrials.gov · NCT06809712 (opens the source filing in a new tab)

48. Trial

    Study registered

    Apr 22, 2022

    Depression, Anxiety Disorders · ACTIVE_NOT_RECRUITING · sponsor: University of California, San Francisco · SKY Breath Intervention

    ClinicalTrials.gov · NCT05388110 (opens the source filing in a new tab)

49. Trial

    PHASE2 registered

    Mar 29, 2022

    Relapsed or Refractory Acute Myeloid Leukemia (AML) · UNKNOWN · sponsor: Tarapeutics Science Inc. · A Study of HYML-122 and Cytarabine in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

    ClinicalTrials.gov · NCT05241093 (opens the source filing in a new tab)

50. Grant

    R01 · $366k · non-dilutive

    Mar 15, 2022

    FLORIDA STATE UNIVERSITY · PI LI, YAN · NINDS · award ends Feb 28, 2027 · Engineering Extracellular Vesicles of Human Brain Organoids for Stroke Therapy

    NIH RePORTER · NIH RePORTER 11301903 (opens the source filing in a new tab)

51. Grant

    R01 · $661k · non-dilutive

    Mar 8, 2022

    UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI XU, DUAN · NCI · award ends Feb 28, 2027 · Quantitative Steady-State and Dynamic Metabolic MRI for Evaluating Patients with Glioma

    NIH RePORTER · NIH RePORTER 11262826 (opens the source filing in a new tab)

52. Trial

    Study registered

    Dec 1, 2019

    Nocturnal Hypertension · RECRUITING · sponsor: Shanghai Institute of Hypertension · Registry Study on "Control Nocturnal Hypertension to Reach the Target "

    ClinicalTrials.gov · NCT04137549 (opens the source filing in a new tab)

53. Trial

    PHASE1 registered

    Nov 19, 2019

    Glioblastoma Multiforme (GBM) · COMPLETED · sponsor: Susan Chang · Hyperpolarized Carbon-13 (13C) Pyruvate Imaging in Patients With Glioblastoma

    ClinicalTrials.gov · NCT04019002 (opens the source filing in a new tab)

54. Trial

    PHASE4 registered

    Oct 8, 2019

    Hypertension · COMPLETED · sponsor: Shanghai Institute of Hypertension · Gastrodia and Uncaria Recipe in Treating Stage-one Hypertension: an Evidence-based Optimization Study

    ClinicalTrials.gov · NCT04035824 (opens the source filing in a new tab)

55. Trial

    Study registered

    Jul 18, 2018

    Hypertension, Blood Pressure, Cardiovascular Diseases · RECRUITING · sponsor: Yan Li · A Registry Study on the "Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients"

    ClinicalTrials.gov · NCT03547856 (opens the source filing in a new tab)

56. Grant

    R01 · $556k · non-dilutive

    May 1, 2018

    OREGON HEALTH & SCIENCE UNIVERSITY · PI LI, YAN · NEI · award ends Feb 28, 2030 · Artificial Intelligence Assisted Optical Coherence Tomography for Differential Diagnosis and Management of Irregular Corneas

    NIH RePORTER · NIH RePORTER 11290757 (opens the source filing in a new tab)

57. Trial

    PHASE1/PHASE2 registered

    Feb 20, 2018

    Safety and Efficacy · ACTIVE_NOT_RECRUITING · sponsor: The First Affiliated Hospital of Soochow University · Study of T Cells Targeting CD19/BCMA (CART-19/BCMA) for High Risk Multiple Myeloma Followed With Auto-HSCT

    ClinicalTrials.gov · NCT03455972 (opens the source filing in a new tab)

58. Trial

    Study registered

    Feb 1, 2018

    Acute Lymphoblastic Leukemia, Pediatric · COMPLETED · sponsor: The Children's Hospital of Zhejiang University School of Medicine · MRD Detection by NGS in Pediatric T-ALL

    ClinicalTrials.gov · NCT06525116 (opens the source filing in a new tab)

59. Grant

    R01 · $548k · non-dilutive

    Aug 3, 2017

    CASE WESTERN RESERVE UNIVERSITY · PI JIN, FULAI · NHGRI · award ends May 31, 2027 · Robust mapping of chromatin loops from sparse or single cell Hi-C data with DeepLoop

    NIH RePORTER · NIH RePORTER 11360641 (opens the source filing in a new tab)

60. Trial

    PHASE4 registered

    Feb 14, 2017

    Masked Hypertension · COMPLETED · sponsor: Yan Li · Antihypertensive Treatment in Masked Hypertension

    ClinicalTrials.gov · NCT02893358 (opens the source filing in a new tab)

61. Trial

    PHASE1 registered

    Jan 11, 2017

    Recurrent World Health Organization (WHO) Grade II Glioma, Recurrent WHO Grade III Glioma, WHO Grade II Glioma, WHO Grade III Glioma · RECRUITING · sponsor: Susan Chang · Serial MR Imaging and MR Spectroscopic Imaging for the Characterization of Lower Grade Glioma

    ClinicalTrials.gov · NCT04540107 (opens the source filing in a new tab)

62. Trial

    PHASE1 registered

    Dec 9, 2015

    Glioma · RECRUITING · sponsor: Susan Chang · Hyperpolarized Imaging in Diagnosing Participants With Glioma

    ClinicalTrials.gov · NCT03739411 (opens the source filing in a new tab)

63. Grant

    R01 · $777k · non-dilutive

    Apr 1, 2014

    UNIVERSITY OF WISCONSIN-MADISON · PI ATTIE, ALAN D · NIDDK · award ends Dec 31, 2030 · The Diversity Outbred Diabetes Project

    NIH RePORTER · NIH RePORTER 11291706 (opens the source filing in a new tab)

64. Grant

    P41 · $323k · non-dilutive

    Aug 1, 2011

    UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI XU, DUAN · NIBIB · award ends Feb 28, 2027 · Acquisition and Analysis Methods for Hyperpolarized MR Data

    NIH RePORTER · NIH RePORTER 11307054 (opens the source filing in a new tab)

65. Grant

    P30 · $273k · non-dilutive

    Sep 12, 1997

    OHIO STATE UNIVERSITY · PI LIU, BEI · NCI · award ends Mar 31, 2031 · Shared Resource 07: Flow Cytometry (FCSR)

    NIH RePORTER · NIH RePORTER 11263199 (opens the source filing in a new tab)